疾病病因与结肠切除指征对术后结局的影响:NSQIP结肠切除靶向数据库研究
该回顾性研究利用ACS NSQIP结肠切除靶向数据库2012–2022年数据,比较结肠癌、感染性病因和炎症性肠病(IBD)行结肠切除患者的30天术后结局。调整术前危险因素后,IBD患者发生并发症的比值比显著高于结肠癌(OR 1.3,95%CI 1.1–1.4)和感染性病因(OR 1.3,95%CI 1.2–1.4),且静脉血栓栓塞、手术部位感染、肠梗阻延长和30天再入院风险均更高。
要点
- 结肠切除指征影响术后结局,IBD患者并发症风险高于结肠癌和感染性病因。
- 未调整分析中感染性病因患者死亡率和并发症率最高。
- 基于病因的风险调整结局报告有助于识别高危患者和制定针对性质量改进措施。
核心结论
- 结肠切除的指征影响术后结局,IBD患者调整后并发症风险显著高于结肠癌和感染性病因患者。
研究设计与样本
- 回顾性研究,使用ACS NSQIP结肠切除靶向数据库2012–2022年数据,纳入结肠癌158,560例、感染性病因90,827例、IBD 30,548例行结肠切除的患者,采用逻辑回归模型调整术前危险因素比较30天术后结局。
主要发现
- 未调整分析中,感染性病因患者死亡率为2.6%、并发症率为27.6%,均为最高。
- 调整协变量后,IBD患者发生并发症的比值比显著高于结肠癌(OR 1.3,95%CI 1.1–1.4)和感染性病因(OR 1.3,95%CI 1.2–1.4)。
- IBD患者发生静脉血栓栓塞、手术部位感染、肠梗阻延长和30天再入院的比值比显著高于结肠癌和感染性病因患者。
临床怎么用
- 临床报告结肠切除结局时应考虑病因分层,以更准确识别高危患者并改进基准比较。
- 针对IBD等高风险病因患者,可制定针对性质量改进措施以改善术后结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American College of Surgeons (ACS) NSQIP Colectomy-Targeted database provides valuable metrics on surgical outcomes by using clinical data to enhance quality improvement efforts. However, the quality measures offered in the ACS NSQIP semiannual report do not stratify for the indication of colectomy. We aim to compare postoperative outcomes in patients undergoing colectomy for colon cancer, infectious causes, and inflammatory bowel disease (IBD). STUDY DESIGN: A retrospective review of patients undergoing colectomy was performed using the ACS NSQIP Colectomy-Targeted database from 2012 to 2022. Logistic regression models were used to compare the 30-day postoperative outcomes of patients who underwent colectomy for colon cancer, infectious causes, and IBD while adjusting for preoperative risk factors. RESULTS: There were 158,560 patients who underwent colectomy for colon cancer, 90,827 patients for infectious causes, and 30,548 patients for IBD. In unadjusted analysis, patients undergoing colectomy for infectious causes had the highest rates of mortality (2.6%) and morbidity (27.6%). After adjusting for covariates, patients with IBD undergoing colectomy had significantly higher odds of morbidity compared to those undergoing colectomy for colon cancer (odds ratio 1.3, 95% CI [1.1 to 1.4]) and infectious causes (odds ratio 1.3 [1.2 to 1.4]). Patients with IBD had significantly higher odds of experiencing venous thromboembolism, surgical site infections, prolonged ileus, and readmission within 30 days compared to both colon cancer and infectious causes patients. CONCLUSIONS: This study demonstrates that the indication for colectomy impacts postoperative outcomes. Reporting risk-adjusted outcomes based on the underlying disease etiology could lead to identifying high-risk patients, improving benchmarking outcomes, and developing targeted quality initiatives.
引用
- Podder SK, Doermann A, Ibrahim G, et al. Impact of Disease Etiology and Indication for Colectomy on Postoperative Outcomes: NSQIP Colectomy-Targeted Database Study. J Am Coll Surg. 2025. PMID: 39807794. doi:10.1097/XCS.0000000000001280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。